Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans
Authors
Keywords
-
Journal
Viruses-Basel
Volume 13, Issue 11, Pages 2325
Publisher
MDPI AG
Online
2021-11-22
DOI
10.3390/v13112325
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The puzzle of the COVID-19 pandemic in Africa
- (2021) Justin M. Maeda et al. SCIENCE
- Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
- (2021) Elizabeth M. Anderson et al. CELL
- Challenges in interpreting SARS-CoV-2 serological results in African countries
- (2021) Antoine Nkuba Ndaye et al. Lancet Global Health
- Post-Ebola syndrome presents with multiple overlapping symptom clusters: evidence from an ongoing cohort study in Eastern Sierra Leone
- (2021) Nell G Bond et al. CLINICAL INFECTIOUS DISEASES
- Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses
- (2021) Jennifer Hicks et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
- (2021) Ge Song et al. Nature Communications
- Previous Humoral Immunity to the Endemic Seasonal Alphacoronaviruses NL63 and 229E Is Associated with Worse Clinical Outcome in COVID-19 and Suggests Original Antigenic Sin
- (2021) Daniele Focosi et al. Life-Basel
- Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail
- (2021) Arnaud C. Drouin et al. Viruses-Basel
- What Could Explain the Lower COVID-19 Burden in Africa despite Considerable Circulation of the SARS-CoV-2 Virus?
- (2021) Richard G. Wamai et al. International Journal of Environmental Research and Public Health
- Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France
- (2021) Tom Woudenberg et al. EBioMedicine
- Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers
- (2021) Shelley Klompus et al. Science Immunology
- The Conundrum of Low COVID-19 Mortality Burden in sub-Saharan Africa: Myth or Reality?
- (2021) Janica Adams et al. Global Health-Science and Practice
- COVID-19 in Africa: preexisting immunity and HIV
- (2021) Jumari Snyman et al. AIDS
- A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
- (2021) Eduan Wilkinson et al. SCIENCE
- Identification of Common CD8+ T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone
- (2020) Saori Sakabe et al. JOURNAL OF VIROLOGY
- Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
- (2020) Sisi Kang et al. Acta Pharmaceutica Sinica B
- Global Seasonality of Human Seasonal Coronaviruses: A Clue for Postpandemic Circulating Season of Severe Acute Respiratory Syndrome Coronavirus 2?
- (2020) You Li et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
- (2020) Ching-Lin Hsieh et al. SCIENCE
- Wide Diversity of Coronaviruses in Frugivorous and Insectivorous Bat Species: A Pilot Study in Guinea, West Africa
- (2020) Audrey Lacroix et al. Viruses-Basel
- The relatively young and rural population may limit the spread and severity of COVID-19 in Africa: a modelling study
- (2020) Binta Zahra Diop et al. BMJ Global Health
- High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2
- (2020) Luca Zinzula et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Seasonal coronavirus protective immunity is short-lasting
- (2020) Arthur W. D. Edridge et al. NATURE MEDICINE
- COVID-19 in Africa: Dampening the storm?
- (2020) Moustapha Mbow et al. SCIENCE
- Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages
- (2020) Megan L. Heinrich et al. Scientific Reports
- Covid-19: Do many people have pre-existing immunity?
- (2020) Peter Doshi BMJ-British Medical Journal
- Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection
- (2020) Daniel Poston et al. CLINICAL INFECTIOUS DISEASES
- High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa
- (2020) For Yue Tso et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Recent endemic coronavirus infection is associated with less-severe COVID-19
- (2020) Manish Sagar et al. JOURNAL OF CLINICAL INVESTIGATION
- Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization
- (2019) Kathryn M. Hastie et al. CELL
- MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity
- (2018) Daniel K. W. Chu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MERS-CoV spillover at the camel-human interface
- (2018) Gytis Dudas et al. eLife
- High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia
- (2018) Abeer N. Alshukairi et al. mBio
- Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya
- (2018) Sheila Ommeh et al. VIROLOGICA SINICA
- Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications
- (2017) K.H. Kim et al. JOURNAL OF HOSPITAL INFECTION
- Surveillance of Bat Coronaviruses in Kenya Identifies Relatives of Human Coronaviruses NL63 and 229E and Their Recombination History
- (2017) Ying Tao et al. JOURNAL OF VIROLOGY
- Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever
- (2017) Chad E Mire et al. NATURE MEDICINE
- Structural basis for antibody-mediated neutralization of Lassa virus
- (2017) Kathryn M. Hastie et al. SCIENCE
- An Outbreak of Ebola Virus Disease in the Lassa Fever Zone
- (2016) Augustine Goba et al. JOURNAL OF INFECTIOUS DISEASES
- Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
- (2016) James E. Robinson et al. Nature Communications
- Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus
- (2015) Kristian G. Andersen et al. CELL
- Evidence for an Ancestral Association of Human Coronavirus 229E with Bats
- (2015) Victor Max Corman et al. JOURNAL OF VIROLOGY
- Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study
- (2015) Marcel A Müller et al. LANCET INFECTIOUS DISEASES
- Lassa Fever in Post-Conflict Sierra Leone
- (2014) Jeffrey G. Shaffer et al. PLoS Neglected Tropical Diseases
- Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression
- (2011) K. M. Hastie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection
- (2011) Luis M Branco et al. Virology Journal
- Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor
- (2009) K. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started